Pharmacokinetics and pharmacodynamics of propofol in patients undergoing abdominal aortic surgery.

Journal Title: Pharmacological Reports - Year 2012, Vol 64, Issue 1

Abstract

Available propofol pharmacokinetic protocols for target-controlled infusion (TCI) were obtained from healthy individuals. However, the disposition as well as the response to a given drug may be altered in clinical conditions. The aim of the study was to examine population pharmacokinetics (PK) and pharmacodynamics (PD) of propofol during total intravenous anesthesia (propofol/fentanyl) monitored by bispectral index (BIS) in patients scheduled for abdominal aortic surgery. Population nonlinear mixed-effect modeling was done with Nonmem. Data were obtained from ten male patients. The TCI system (Diprifusor) was used to administer propofol. The BIS index served to monitor the depth of anesthesia. The propofol dosing was adjusted to keep BIS level between 40 and 60. A two-compartment model was used to describe propofol PK. The typical values of the central and peripheral volume of distribution, and the metabolic and inter-compartmental clearance were V(C) = 24.7 l, V(T) = 112 l, Cl = 2.64 l/min and Q = 0.989 l/min. Delay of the anesthetic effect, with respect to plasma concentrations, was described by the effect compartment with the rate constant for the distribution to the effector compartment equal to 0.240 min(-1). The BIS index was linked to the effect site concentrations through a sigmoidal E(max) model with EC(50) = 2.19 mg/l. The body weight, age, blood pressure and gender were not identified as statistically significant covariates for all PK/PD parameters. The population PK/PD model was successfully developed to describe the time course and variability of propofol concentration and BIS index in patients undergoing surgery.

Authors and Affiliations

Paweł Wiczling, Agnieszka Bienert, Roma Hartmann-Sobczyńska, Krzysztof Bieda, Aleksandra Marcinkowska, Maria Malatyńska, Roman Kaliszan, Edmund Grześkowiak

Keywords

Related Articles

Locomotor activity changes in female adolescent and adult rats during repeated treatment with a cannabinoid or club drug.

Adolescents and young adults of both sexes are the primary consumers of "club" drugs; yet, most of the mechanistic preclinical research in this area has been performed in adult male rodents. The purpose of this study was...

Dopaminergic drug-induced modulation of the expression of the dopamine transporter in peripheral blood lymphocytes in Parkinson's disease.

The modulation of expression of the dopamine transporter by dopaminergic drugs was investigated by flow cytometry in peripheral blood lymphocytes from patients suffering Parkinson's disease. An 8-week in vivo exposure to...

Biological actions of lipoic acid associated with sulfane sulfur metabolism.

This work aimed to investigate the effect of lipoic acid (LA) on sulfane sulfur (S(*)) level and rhodanese activity in rat tissues. In vitro studies conduced so far have indicated that dihydrolipoic acid serves as an S(*...

Epicutaneous immunization with protein antigen induces antigen-non-specific suppression of CD8 T cell mediated contact sensitivity.

Allergic contact dermatitis (ACD) resulting from exposure to low molecular weight chemicals is a common clinical condition in industrialized countries and can be mediated by either Th1 or Tc1 lymphocytes. The animal mode...

Glycoprotein (116 kD) isolated from Ulmus davidiana Nakai protects from injury of 12-O-tetradecanoylphorbol 13-acetate (TPA)-treated BNL CL.2 cells.

Ulmus davidiana Nakai (UDN) has been used for a long time to cure inflammation in oriental medicine. To evaluate the cytoprotective effects of the UDN glycoprotein, we measured cytotoxicity, the level of intracellular re...

Download PDF file
  • EP ID EP108712
  • DOI -
  • Views 88
  • Downloads 0

How To Cite

Paweł Wiczling, Agnieszka Bienert, Roma Hartmann-Sobczyńska, Krzysztof Bieda, Aleksandra Marcinkowska, Maria Malatyńska, Roman Kaliszan, Edmund Grześkowiak (2012). Pharmacokinetics and pharmacodynamics of propofol in patients undergoing abdominal aortic surgery.. Pharmacological Reports, 64(1), 113-122. https://europub.co.uk/articles/-A-108712